Phenidone Blocks the Increases of Proenkephalin and Prodynorphin

Total Page:16

File Type:pdf, Size:1020Kb

Phenidone Blocks the Increases of Proenkephalin and Prodynorphin Brain Research 782Ž. 1998 337±342 Short communication Phenidone blocks the increases of proenkephalin and prodynorphin gene expression induced by kainic acid in rat hippocampus: involvement of Fos-related antigene protein Hyoung-Chun Kim a,), Jeong-Hye Suh a, Je-Seong Won b, Wang-Kee Jhoo a, Dong-Keun Song b, Yung-Hi Kim b, Myung-Bok Wie b, Hong-Won Suh b a College of Pharmacy, Kangwon National UniÕersity, Chunchon 200-701, Kangwon-Do, South Korea b Department of Pharmacology, Institute of Natural Medicine, College of Medicine, Hallym UniÕersity, Chunchon 200-701, Kangwon-Do, South Korea Accepted 11 November 1997 Abstract To determine the possible role of cyclooxygenaserlipoxygenase pathway in the regulation of proenkephalinŽ. proENK and prodynorphinŽ. proDYN gene expression induced by kainic acid Ž. KA in rat hippocampus, the effects of esculetin, aspirin, or phenidone on the seizure activity, proENK and proDYN mRNA levels, and the level of fos-related antigeneŽ. Fra protein induced by KA in rat hippocampus were studied. EsculetinŽ.Ž 5 mgrkg , aspirin 15 mgrkg . , or phenidone Ž 50 mgrkg . was administered orally five times every 12 h before the injection of KAŽ. 10 mgrkg, i.p. Seizure activity induced by KA was significantly attenuated by phenidone. However, neither esculetin nor aspirin affected KA-induced seizure activity. The proENK and proDYN mRNA levels were markedly increased 4 and 24 h after KA administration. The elevations of both proENK and proDYN mRNA levels induced by KA were inhibited by pre-administration with phenidone, but not with esculetin and aspirin. ProENK-like protein level increased by KA administration was also inhibited by pre-administration with phenidone, but not with esculetin and aspirin. The increases of proENK and proDYN mRNA levels induced by KA were well correlated with the increases of Fra protein level. Additionally, the induction of Fra protein was inhibited by pre-administration with phenidone, but not with esculetin and aspirin. The results suggest that blockade of both cyclooxygenase and lipoxygenase pathways appears to be responsible for increases of proENK and proDYN mRNA levels induced by KA via inhibiting the induction of Fra protein in rat hippocampus. q 1998 Elsevier Science B.V. Keywords: Kainic acid; Cyclooxygenase; Lipoxygenase; Proenkephalin; Prodynorphin; Fra protein; Hippocampus Kainic acidŽ. KA , a unique neuroexcitatoryrneurotoxic cortexwx 13,19 . In addition, the increases of c-Fos, Fra, and substance, produces seizure and neural degeneration in the Jun proteins induced by convulsant dose of KA correlate mammalian CNS, and appears to provide a good model for with AP-1 DNA binding activitywx 18,19 . The neurons of some aspects of human temporal lobe epilepsywx 3,17 . In the hippocampus express both proENK and proDYN the rat hippocampus, KA receptors are concentrated in the mRNA and their protein productswx 11,15 . These proENK CA3rCA4 regions, with moderate levels in the other areas and proDYN mRNA levels are also elevated by KAwx 9 . of the hippocampuswx 8,12 . Both proENK and proDYN genes contain an AP-1-like Several types of proto-oncogene product, such as Fos domain in their promoter regionswx 7,10 . and Jun family proteins, serve as the third messengers in Cis-unsaturated fatty acids can be liberated by phospho- wx the regulation of various types of genes 4,14 . These lipase A2 or diacylglycerol lipase and serve as a precursor, proteins interact with AP-1 domain in the promoter of and subsequently metabolized further via the action of various types of genes, in turn, modulate the transcrip- cyclooxygenase and lipoxygenasewx 5 . Recently, Suh et al. tional activitywx 16 . Convulsant doses of KA induce c-Fos, wx21,22 have reported that arachidonic acid or prosta- Fra, and Jun proteins in rat hippocampus and entorhinal glandin E2 increases proENK mRNA levels in bovine chromaffin cells. However, the involvement of cyclooxy- genase and lipoxygenase pathways in KA-induced increase ) Corresponding author. Fax: q82-361-55-7865. of opioid peptides mRNA in the hippocampus has not been 0006-8993r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved. PII S0006-8993Ž. 97 01401-7 338 H.-C. Kim et al.rBrain Research 782() 1998 337±342 characterized. In an attempt to examine the role of cyclo- sarcosine, 2% blocking reagent. , and hybridized overnight oxygenaserlipoxygenase in the regulation of proENK and in Dig-labeled proenkephalin and prodynorphin probes proDYN mRNA expression, the effects of phenidone, es- containing prehybridization buffer at 688C. Then mem- culetin, and aspirin on KA-induced proENK and proDYN branes were washed twice in 2= wash solutionŽ 2= SSC, mRNA levels, or proENK and Fra proteins were studied in 0.1% SDS. at room temperature, and further washed in the present study. 0.1= wash solutionŽ. 0.1= SSC, 0.1% SDS at 688C for 1 Male Sprague±Dawley rats weighing 200±280 g were h. After equilibrating in a buffer IŽ 100 mM maleic acid, used. Animals were housed two per group in a room 150 mM NaCl, pH 7.5. for 1 min, the membranes were maintained at 22"58C with an alternating 12 h light±dark gently agitated in buffer IIŽ 1% blocking reagent in buffer cycle. Animals were used only once. EsculetinŽ. 5 mgrkg , I. for 30±60 min and immuno reacted with the diluted aspirinŽ. 15 mgrkg , or phenidone Ž. 50 mgrkg was admin- anti-DIG-alkaline phosphatasew 1: 10,000Ž. 75 mUrmlx in istered orally five times every 12 h. Thirty minutes after a buffer II for 30 min. After washing twice for 15 min per the last administration of each drug, KAŽ. 10 mgrkg was wash in 0.3% Tween 20Ž. in buffer I , the membranes were administered intraperitoneally. Then, animals were sacri- equilibrated in a buffer IIIŽ 100 mM Tris±HCl, pH 9.5, ficed 4 and 24 h after KA administration. 100 mM NaCl, 50 mM MgCl2 . for 2 min and added 1:100 Seizure activity was rated during a 4-h period after the diluted CSPDŽ. Boehringer Mannheim, Germany solution, KA challenge according to the scale devised by Baran et a chemi-luminescent substrate solution, in buffer III. After al.wx 1 . The seizure rating scale were as follows: 0; normal, incubation at 378C for 15±20 min, the membranes were rare wet-dog shakesŽ. WDS , no convulsions, 1; intermedi- exposed to Hyperfilm-MPŽ Amersham, Buckinghamshire, ate numbers of WDS, rare convulsion type A, 2; frequent England. For re-hybridization, membranes were washed WDS, frequent type A convulsionsŽ no rearing or salva- for 20 min at room temperature in sterile millepore water, tion. , 3; frequent WDS, frequent type A convulsion, ap- then further washed for overnight at 658Cin50mM pearance of type B convulsions with rearingŽ but without Tris±HCl, pH 8.0, 50% dimethylformamide and 1% SDS, falling. , salivation, 4; WDS, type A convulsions, frequent and re-hybridized to Dig-labeled rat cyclophilin cRNA type B convulsions with falling, salivation, 5; continuous probe as a internal loading control. generalized limbic seizures, death within 3 h. Type A All data shown in the present study were repeated at convulsions: focal convulsions affecting head and extremi- least three-times and showed the same tendency of results. ties, starting 30 min after KA injection. Type B convul- No animal received phenidone, esculetin or aspirin alone sions: frequent generalized convulsions usually starting exhibited seizure behaviorŽ. data not shown . The rats 60±90 min after KA injection. Surviving rats expressed receiving KAŽ. 10 mgrkg manifested robust behavioral recurrent seizure behavior. seizures lasting 4 to 6 hŽ. Fig. 1A . Increased seizure scores Animals from each group were anesthetized with 50 induced by KA were significantly attenuated by the pre- mgrkg pentobarbital and then perfused transcardially with treatment with phenidoneŽ. Fig. 1A . However, neither a 140 ml syringe containing salineŽ 40 mlr100 g body esculetin nor aspirin affected KA-induced responseŽ Fig. weight.Ž followed by 4% paraformaldehyde 70 mlr100 g 1A. body weight. The brains were then removed, stored in 4% Both hippocampal proENK and proDYN mRNA levels paraformaldehyde overnight and then cut at 40 mm in the were not altered in the animals treated with saline, horizontal plane with a vibratome. Prior to overnight incu- phenidone, esculetin or aspirin aloneŽ. Fig. 1B . Both bation in primary antibody, sections were prewashed in proENK and proDYN mRNA levels were remarkably in- 0.2% Triton X-100 for 15 min, followed by 4% normal creased 4 and 24 h after KA administration. Six hours after goat serum for 20 min. After a 24-h incubation with the KA injection, in all nonseizing rats given KA plus primary Fra antiseraŽ. 1:1000 dilution or proENK antisera phenidone, esculetin or aspirin, the levels of proENK and Ž.1:1000 dilution , sections were then incubated with a proDYN mRNA was sightly increased. However, these secondary biotinylated antiserumŽ. 1:500 dilution for 1 h. levels were returned to the basal level after 24 h after KA Sections were always washed three times with PBSŽ pH administrationŽ. Fig. 1B . Seizing rats pretreated with 7.4. between each incubation step. As the chromogen, phenidone, but not esculetin and aspirin, exhibited de- X 3.3 -diaminobenzidine was used. creases in both proENK and proDYN mRNA levels at all Total cellular RNA and proteins were extracted from time pointsŽ. Fig. 1B . pooled rat hippocampus Ž.ns3rgroup using a rapid Hippocampal proENK-like immunoreactivity or Fra-im- guanidine thiocyanate±water saturated phenolrchloroform munoreactivity was not affected by the treatment with extraction and subsequent precipitation with acidic sodium phenidone, esculetin or aspirin aloneŽ. data not shown . As acetatewx 6 . A total of 10 mg of total RNA were elec- shown in Figs. 2 and 3, KA significantly increased proENK trophoresed and transferred on nylon membrane.
Recommended publications
  • Analytical Performance of an Immunoassay to Measure Proenkephalin ⁎ Leslie J
    Clinical Biochemistry xxx (xxxx) xxx–xxx Contents lists available at ScienceDirect Clinical Biochemistry journal homepage: www.elsevier.com/locate/clinbiochem Analytical performance of an immunoassay to measure proenkephalin ⁎ Leslie J. Donatoa, ,Jeffrey W. Meeusena, John C. Lieskea, Deborah Bergmannc, Andrea Sparwaßerc, Allan S. Jaffea,b a Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, United States b Division of Cardiology, Mayo Clinic, Rochester, MN 55905, United States c Sphingotec GmbH, Hennigsdorf, Germany ARTICLE INFO ABSTRACT Keywords: Background: Endogenous opioids, enkephalins, are known to increase with acute kidney injury. Since the mature Biomarkers pentapeptides are unstable, we evaluated the performance of an assay that measures proenkephalin 119–159 Proenkephalin (PENK), a stable peptide formed concomitantly with mature enkephalins. Enkephalin Methods: PENK assay performance was evaluated on two microtiterplate/chemiluminescence sandwich im- Pro-enkephalin munoassay formats that required 18 or 1 h incubation times. PENK concentration was measured in plasma from penKid healthy individuals to establish a reference interval and in patients with varied levels of kidney function and Assay validation comorbidities to assess the association with measured glomerular filtration rate (mGFR) using iothalamate clearance. Results: Assay performance characteristics in plasma were similar between the assay formats. Limit of quanti- tation was 26.0 pmol/L (CV = 20%) for the 1 h assay and 17.3 pmol/L (CV = 3%) for the 18 h assay. Measurable ranges were 26–1540 pmol/L (1 h assay) and 18–2300 pmol/L (18 h assay). PENK concentrations are stable in plasma stored ambient to 10 days, refrigerated to at least 15 days, and frozen to at least 90 days.
    [Show full text]
  • Screening of 109 Neuropeptides on Asics Reveals No Direct Agonists
    www.nature.com/scientificreports OPEN Screening of 109 neuropeptides on ASICs reveals no direct agonists and dynorphin A, YFMRFamide and Received: 7 August 2018 Accepted: 14 November 2018 endomorphin-1 as modulators Published: xx xx xxxx Anna Vyvers, Axel Schmidt, Dominik Wiemuth & Stefan Gründer Acid-sensing ion channels (ASICs) belong to the DEG/ENaC gene family. While ASIC1a, ASIC1b and ASIC3 are activated by extracellular protons, ASIC4 and the closely related bile acid-sensitive ion channel (BASIC or ASIC5) are orphan receptors. Neuropeptides are important modulators of ASICs. Moreover, related DEG/ENaCs are directly activated by neuropeptides, rendering neuropeptides interesting ligands of ASICs. Here, we performed an unbiased screen of 109 short neuropeptides (<20 amino acids) on fve homomeric ASICs: ASIC1a, ASIC1b, ASIC3, ASIC4 and BASIC. This screen revealed no direct agonist of any ASIC but three modulators. First, dynorphin A as a modulator of ASIC1a, which increased currents of partially desensitized channels; second, YFMRFamide as a modulator of ASIC1b and ASIC3, which decreased currents of ASIC1b and slowed desensitization of ASIC1b and ASIC3; and, third, endomorphin-1 as a modulator of ASIC3, which also slowed desensitization. With the exception of YFMRFamide, which, however, is not a mammalian neuropeptide, we identifed no new modulator of ASICs. In summary, our screen confrmed some known peptide modulators of ASICs but identifed no new peptide ligands of ASICs, suggesting that most short peptides acting as ligands of ASICs are already known. Acid-sensing ion channels form a small family of proton-gated ion channels that belongs to the degenerin/epi- thelial Na+ channel (DEG/ENaC) gene family1.
    [Show full text]
  • Regulatory Strategies for Promoting the Safe Use of Prescription Opioids and the Potential Impact of Overregulation
    REGULATORY STRATEGIES FOR PROMOTING THE SAFE USE OF PRESCRIPTION OPIOIDS AND THE POTENTIAL IMPACT OF OVERREGULATION Wissenschaftliche Prüfungsarbeit zur Erlangung des Titels „Master of Drug Regulatory Affairs“ der Mathematisch-Naturwissenschaftlichen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn vorgelegt von Dr. Katja Bendrin aus Torgau Bonn 2020 Betreuer und Erster Referent: Dr. Birka Lehmann Zweiter Referent: Dr. Jan Heun REGULATORY STRATEGIES FOR PROMOTING THE SAFE USE OF PRESCRIPTION OPIOIDS AND THE POTENTIAL IMPACT OF OVERREGULATION Acknowledgment │ page II of VII Acknowledgment I want to thank Dr. Birka Lehmann for her willingness to supervise this work and for her support. I further thank Dr. Jan Heun for assuming the role of the second reviewer. A big thank you to the DGRA Team for the organization of the master's course and especially to Dr. Jasmin Fahnenstich for her support to find the thesis topic and supervisors. Furthermore, thank you Harald for your patient support. REGULATORY STRATEGIES FOR PROMOTING THE SAFE USE OF PRESCRIPTION OPIOIDS AND THE POTENTIAL IMPACT OF OVERREGULATION Table of Contents │ page III of VII Table of Contents 1. Scope.................................................................................................................................... 1 2. Introduction ......................................................................................................................... 2 2.1 Classification of Opioid Medicines .................................................................................................
    [Show full text]
  • Narcotic Analgesics I Blanton SLIDE 1: We Will Be Spending the Next 90 Minutes Discussing Narcotic Analgesics- That Is Morphine, Oxycodone, Heroin, Etc
    Narcotic Analgesics I Blanton SLIDE 1: We will be spending the next 90 minutes discussing narcotic analgesics- that is morphine, oxycodone, heroin, etc. These drugs act primarily thru the opiate receptor system. I always like to begin by presenting two factoids that I believe illustrate the power of this system: (1) Ok imagine you are in pain! Now I tell you that I am going to give you an injection of morphine or heroin. Even if I instead give you an injection of just saline- 50% of you will report that your pain is significantly reduced- that is quite a placebo effect. However, if instead of saline I give you an injection of Naloxone, an opiate receptor antagonist- the placebo effect is eliminated. In other words you are activating your opiate receptor system to induce analgesia. (2) acupuncture can be used to reduce pain. However, Naloxone will block this effect- in otherwords the acupuncture is activating your opiate receptor system. SLIDE 1A: The use of narcotic analgesics for effective pain management has certainly had its flip side……. With prescription narcotic analgesics helping to fuel the current heroin epidemic…. Back to SLIDE 1: So narcotic analgesics. The name narcotic is somewhat misleading, because it implies narcosis or somnolence. The name opiate or opioid is more precise because it connotes analgesia, without causing sleep or loss of consciousness. SLIDE 2: The terms opiate or opioid, as you are probably aware, refers to opium, the crude extract of the Poppy plant, Papaver somniferum. Opium comes from the seed pod of the plant after the petals have dropped.
    [Show full text]
  • The Role of Protein Convertases in Bigdynorphin and Dynorphin a Metabolic Pathway
    Université de Montréal The Role of Protein Convertases in Bigdynorphin and Dynorphin A Metabolic Pathway par ALBERTO RUIZ ORDUNA Département de biomédecine vétérinaire Faculté de médecine vétérinaire Mémoire présenté à la Faculté de médecine vétérinaire en vue de l’obtention du grade de maître ès sciences (M.Sc.) en sciences vétérinaires option pharmacologie Décembre, 2015 © Alberto Ruiz Orduna, 2015 Résumé Les dynorphines sont des neuropeptides importants avec un rôle central dans la nociception et l’atténuation de la douleur. De nombreux mécanismes régulent les concentrations de dynorphine endogènes, y compris la protéolyse. Les Proprotéines convertases (PC) sont largement exprimées dans le système nerveux central et clivent spécifiquement le C-terminale de couple acides aminés basiques, ou un résidu basique unique. Le contrôle protéolytique des concentrations endogènes de Big Dynorphine (BDyn) et dynorphine A (Dyn A) a un effet important sur la perception de la douleur et le rôle de PC reste à être déterminée. L'objectif de cette étude était de décrypter le rôle de PC1 et PC2 dans le contrôle protéolytique de BDyn et Dyn A avec l'aide de fractions cellulaires de la moelle épinière de type sauvage (WT), PC1 -/+ et PC2 -/+ de souris et par la spectrométrie de masse. Nos résultats démontrent clairement que PC1 et PC2 sont impliquées dans la protéolyse de BDyn et Dyn A avec un rôle plus significatif pour PC1. Le traitement en C-terminal de BDyn génère des fragments peptidiques spécifiques incluant dynorphine 1-19, dynorphine 1-13, dynorphine 1-11 et dynorphine 1-7 et Dyn A génère les fragments dynorphine 1-13, dynorphine 1-11 et dynorphine 1-7.
    [Show full text]
  • Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions
    Molecular Pharmacology Fast Forward. Published on June 2, 2020 as DOI: 10.1124/mol.120.119388 This article has not been copyedited and formatted. The final version may differ from this version. File name: Opioid peptides v45 Date: 5/28/20 Review for Mol Pharm Special Issue celebrating 50 years of INRC Five decades of research on opioid peptides: Current knowledge and unanswered questions Lloyd D. Fricker1, Elyssa B. Margolis2, Ivone Gomes3, Lakshmi A. Devi3 1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; E-mail: [email protected] 2Department of Neurology, UCSF Weill Institute for Neurosciences, 675 Nelson Rising Lane, San Francisco, CA 94143, USA; E-mail: [email protected] 3Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, Annenberg Downloaded from Building, One Gustave L. Levy Place, New York, NY 10029, USA; E-mail: [email protected] Running Title: Opioid peptides molpharm.aspetjournals.org Contact info for corresponding author(s): Lloyd Fricker, Ph.D. Department of Molecular Pharmacology Albert Einstein College of Medicine 1300 Morris Park Ave Bronx, NY 10461 Office: 718-430-4225 FAX: 718-430-8922 at ASPET Journals on October 1, 2021 Email: [email protected] Footnotes: The writing of the manuscript was funded in part by NIH grants DA008863 and NS026880 (to LAD) and AA026609 (to EBM). List of nonstandard abbreviations: ACTH Adrenocorticotrophic hormone AgRP Agouti-related peptide (AgRP) α-MSH Alpha-melanocyte stimulating hormone CART Cocaine- and amphetamine-regulated transcript CLIP Corticotropin-like intermediate lobe peptide DAMGO D-Ala2, N-MePhe4, Gly-ol]-enkephalin DOR Delta opioid receptor DPDPE [D-Pen2,D- Pen5]-enkephalin KOR Kappa opioid receptor MOR Mu opioid receptor PDYN Prodynorphin PENK Proenkephalin PET Positron-emission tomography PNOC Pronociceptin POMC Proopiomelanocortin 1 Molecular Pharmacology Fast Forward.
    [Show full text]
  • Antinociceptive Effect of a Genomic Herpes Simplex Virus-Based Vector Expressing Human Proenkephalin in Rat Dorsal Root Ganglion
    Gene Therapy (2001) 8, 551–556 2001 Nature Publishing Group All rights reserved 0969-7128/01 $15.00 www.nature.com/gt RESEARCH ARTICLE Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion JR Goss1,2, M Mata1,2,3, WF Goins3,HHWu1, JC Glorioso3 and DJ Fink1,2,3 Departments of 1Neurology and 3Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, and 2GRECC, VA Medical Center, Pittsburgh, PA, USA Endogenous opiate peptides acting pre- and post-synap- antinociceptive effect measured by the formalin footpad test, tically in the dorsal horn of spinal cord inhibit transmission that was most prominent in the delayed (‘tonic’) phase 20– of nociceptive stimuli. We transfected neurons of the dorsal 70 min after the administration of formalin. The magnitude root ganglion in vivo by footpad inoculation with 30 ␮l(3× of the antinociceptive effect diminished over 4 weeks after 107 p.f.u.) of a replication-incompetent (ICP4-deleted) her- transduction, but reinoculation of the vector reestablished pes simplex virus (HSV) vector with a cassette containing a the analgesic effect, without evidence for the development portion of the human proenkephalin gene coding for 5 met- of tolerance. The antinociceptive effect was blocked com- and 1 leu-enkephalin molecules under the control of the pletely by intrathecal naltrexone. These results suggest that human cytomegalovirus immediate–early promoter (HCMV gene therapy with an enkephalin-producing herpes-based IEp) inserted in the HSV thymidine kinase (tk) locus. Vector- vector may prove useful in the treatment of pain.
    [Show full text]
  • Structural Basis for Multifunctional Roles of Mammalian Aminopeptidase N
    Structural basis for multifunctional roles of mammalian aminopeptidase N Lang Chen, Yi-Lun Lin, Guiqing Peng, and Fang Li1 Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455 Edited by Ralph S. Baric, University of North Carolina, Chapel Hill, NC, and accepted by the Editorial Board September 21, 2012 (received for review June 13, 2012) Mammalian aminopeptidase N (APN) plays multifunctional roles in sensation and mood regulation by catalyzing the metabolism of many physiological processes, including peptide metabolism, cell neuropeptides that process sensory information. One of these motility and adhesion, and coronavirus entry. Here we determined neuropeptides is enkephalin, which binds to opioid receptors and crystal structures of porcine APN at 1.85 Å resolution and its com- has pain-relief and mood-regulating effects (9). APN degrades plexes with a peptide substrate and a variety of inhibitors. APN is and shortens the in vivo life of enkephalin, and hence enhances a cell surface-anchored and seahorse-shaped zinc-aminopeptidase pain sensation and regulates mood. Second, APN is involved in that forms head-to-head dimers. Captured in a catalytically active blood pressure regulation. APN degrades vasoconstrictive peptide state, these structures of APN illustrate a detailed catalytic mech- angiotensin-III, causing vasodilation and lowered blood pressure anism for its aminopeptidase activity. The active site and peptide- (10). An endogenous APN inhibitor, substance P, blocks both binding channel of APN reside in cavities with wide openings, the enkephalin-dependent and angiotensin-dependent pathways allowing easy access to peptides. The cavities can potentially open (11, 12). Third, APN is overexpressed on the cell surfaces of up further to bind the exposed N terminus of proteins.
    [Show full text]
  • Specific Regions of the Rat Brain
    Proc. Nad. Acad. Sci. USA Vol. 81, pp. 6886-6889, November 1984 Neurobiology Differential processing of prodynorphin and proenkephalin in specific regions of the rat brain (dynorphins/neo-endorphins/[Leulenkephalin/[Metlenkephalin-Arg6-Gly7_Leu'/rat brain nuclei) NADAV ZAMIR*, ECKARD WEBERt, MIKLOS PALKOVITS*, AND MICHAEL BROWNSTEIN* *Laboratory of Cell Biology, National Institute of Mental Health, Bethesda, MD 20205; and tNancy Pritzker Laboratory of Behavioral Neurochemistry, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 Communicated by Seymour S. Kety, July 10, 1984 ABSTRACT Prodynorphin-derived peptides [dynorphin technique, from 300-,um thick frozen coronal sections cut in A (Dyn A)-(1-17), Dyn A-(1-8), Dyn B, a-neo-endorphin, and a cryostat at -10°C (21). Tissue samples were placed in Ep- (3-neo-endorphin] and proenkephalin-derived peptides pendorf tubes containing 200 M1 of0.1 M HC1 and transferred {[Leu]enkephalin ([Leu]Enk) and [Metlenkephalin-Arg6-Gly7- to a boiling water bath for 10 min. Samples were chilled in Leu8 ([Met]Enk-Arg-Gly-Leu)} in selected brain areas of the ice and then homogenized by sonication, and 20-,u aliquots rat were measured by specific radioimmunoassays. We report of the homogenates were removed for protein determination here that different regions of rat brain contain strikingly dif- (22). The extracts were centrifuged at 2000 x g for 10 min at ferent proportions of the prodynorphin and proenkephalin-de- 4°C. The supernatants were transferred to 12 x 75 mm poly- rived peptides. There is a molar excess of a-neo-endorphin- propylene or polystyrene tubes (the latter for RIAs of derived peptides over Dyn B and Dyn A-derived peptides in [Leu]Enk and [Met]Enk-Arg-Gly-Leu) and evaporated to many brain areas.
    [Show full text]
  • Proenkephalin Is a Nuclear Protein Responsive to Growth Arrest and Differentiation Signals Angelika Biittger and Barbara A
    Proenkephalin Is a Nuclear Protein Responsive to Growth Arrest and Differentiation Signals Angelika Biittger and Barbara A. Spruce Department of Anatomy and Physiology, Medical Sciences Institute, University of Dundee, Dundee DD1 4HN, United Kingdom Abstract. Neuropeptide precursors are traditionally structure. In fibroblast cell populations in transition to viewed as molecules destined to be cleaved into bioac- growth arrest, nuclear proenkephalin responds tive peptides, which are then released from the cell to promptly to mitogen withdrawal and cell-cell contact act on target cell surface receptors. In this report we by transient, virtually synchronous unmasking of multi- demonstrate nuclear localization of the enkephalin pre- ple antigenic domains in a fine punctate distribution. A cursor, proenkephalin, in rodent and human embryonic similar phenomenon is observed in myoblasts undergo- fibroblasts (Swiss 3T3 and MRC-5 cells) and in rodent ing differentiation. The acknowledgment of growth ar- myoblasts (C2C12 cells). Nuclear proenkephalin, de- rest and differentiation signals by nuclear proenkepha- tected by immunofluorescence with a panel of anti- lin suggests its integration with transduction pathways proenkephalin monoclonal antibodies, is distributed mediating these signals. predominantly in three patterns. Selective abolition of To begin to address the mechanism of nuclear target- these patterns with salt, nuclease, or methanol is associ- ing, we have transfected mutated and nonmutated ated with liberation of immunoprecipitable proen- proenkephalin into COS (African green monkey kid- kephalin into the extraction supernatant. Proenkepha- ney) cells. Nonmutated proenkephalin is localized ex- lin antigenic domains, mapped using phage display clusively in the cytoplasm; however, proenkephalin mu- libraries and synthetic peptides, are differentially re- tated at the first ATG codon, or devoid of its signal vealed in the three distribution patterns.
    [Show full text]
  • Synthesis and Biological Evaluation of Dynorphin a Analogues As
    AN ABSTRACT OF THE THESIS OF Heekyung Choi for the degree of Doctor of Philosophy in Pharmacy presented on January 10. 1995. Title: Synthesis and Biological Evaluation of Dynorphin A Analogues as Pharmacological Probes of Opioid Receptors. Redacted for Privacy Abstract approved: Jane V. Aldrich, Ph.D. This research involves the preparation of several series of analogues of the opioid peptide dynorphin A (Dyn A) as pharmacological probes of opioid receptors. The peptides were prepared by using Fmoc-solid phase synthesis on either a hydroxymethylphenoxyacetic acid support or a PAL® (Peptide Amide Linker) resin. Biological activity was evaluated by determining binding affinity at opioid receptors L, K, (5) and by measuring opioid activity in the electrically stimulated guinea pig ileum (GPI). As a part of the investigation of the structure-activity relationships of Dyn A, a series of Trp-containing Dyn A-(1-13) analogues were synthesized. During the preparation, significant amounts of side products were identified as derivatives in which Trp was modified. Further studies found that protection of the indole nitrogen of Trp by Boc was the most effective method to suppress the Trp-modification side reaction during acidic cleavage, as compared to cleavage of the peptide without TT protection by various combinations of scavengers (Chapter 4). In the second project, modification of the "message" sequence in [Trp4]Dyn A-(1-13) by replacing Gly2 with various amino acids and their stereoisomers led to changes in opioid receptor affinity and opioid activity. This result may be due to alteration of the conformation of the peptide, in particular the relative orientation of the aromatic residues (Tyr' and Trp4) which are important for opioid activity (Chapter 5).
    [Show full text]
  • Proenkephalin System in Human Polymorphonuclear Cells
    Proenkephalin system in human polymorphonuclear cells. Production and release of a novel 1.0-kD peptide derived from synenkephalin. O Vindrola, … , S Finkielman, V Nahmod J Clin Invest. 1990;86(2):531-537. https://doi.org/10.1172/JCI114740. Research Article In the hematopoietic system a pluripotent stem cell generates precursors for lymphoid and myeloid lineages. Proenkephalin-derived peptides were previously detected in differentiated lymphoid cells. We have studied whether the proenkephalin system is expressed in a typical differentiated cell of the myeloid lineage, the neutrophil. Human peripheral polymorphonuclear cells contain and release proenkephalin-derived peptides. The opioid portion of proenkephalin (met- enkephalin-containing peptides) was incompletely processed, resulting in the absence of low molecular weight products. The nonopioid synenkephalin (proenkephalin 1-70) molecule was completely processed to a 1.0-kD peptide derived from the COOH-terminal. This molecule was characterized in neutrophils by biochemical and immunocytochemical methods. The chemotactic peptide FMLP and the calcium ionophore A23187 induced the release of the proenkephalin-derived peptides, and this effect was potentiated by cytochalasin B. The materials secreted were similar to those present in the cell, although in the supernatant a higher proportion corresponded to more processed products. The 1.0-kD peptide was detected in human, bovine, and rat neutrophils, but the chromatographic pattern of synenkephalin-derived peptides suggests a differential posttranslational processing among species. These findings demonstrate the existence of the proenkephalin system in human neutrophils and the production and release of a novel 1.0-kD peptide derived from the synenkephalin molecule. The presence of opioid peptides in neutrophils suggests their participation in the inflammatory process, including a local analgesic effect.
    [Show full text]